NEW YORK (GenomeWeb News) – Luminex said after the close of the market Wednesday that it will undertake a restructuring that will result in an undisclosed number of employees being laid off and its Brisbane, Australia office being closed.

The Austin, Texas-based molecular diagnostics developer said that the restructuring will focus on its newborn screening group within its Assay and Related Products segment. In total, the firm expects to reduce its workforce by approximately 5 percent. It currently employs nearly 700 people.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

In Genome Biology this week: miRNAs linked to diffuse large B-cell lymphoma outcomes, database of bird genomes, and more.